Online Program

Stiibirth: An Neglected Area in Maternal Child Public Health

Tuesday, November 3, 2015

Joann O'Leary, PhD, MPH, MS, Independent Prenatal Consultant, Minneapolis, MN
Lindsey Wimmer, RN, MSN, CPNP, CPLC, School of Nursing, University of St. Catherines, St. Paul, MN
Stillbirth has been called “one of the last taboos” (Scott, 2011) and “one of the most shamefully neglected areas of public health” (Darmstadt, 2011). Every year, there are 2.6 million babies stillborn around the world (Cousens, et al, 2011), 26,000 of those in the United States alone (MacDorman & Kirmeyer, 2009). If included in causes of death, it would rank 11th in the United States (Paneth, 2012). It is often casually explained as “SIDS before birth”, yet it is ten times more prevalent than SIDS (Fretts, 2010). This presentation will explore the current research on stillbirth, the pregnancy that follows and discuss a model of prenatal attachment intervention that can be offered to all childbearing families, regardless of their culture, to help prevent stillbirth.  Content will include data from a study with elderly parents who did not have supportive education or intervention when their babies died andhow it impacted not only them but siblings alive at the time and those that followed.

Learning Areas:

Implementation of health education strategies, interventions and programs

Learning Objectives:
Identify the prevalence of stillbirth and two ways information on stillbirth and mother's intuition can be incorporated into public health nursing education.

Keyword(s): Birth Outcomes

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have worked in the area of perinatal bereavement for the last 35 years, spoken nationally and internationally as well as published articles and chapters on loss and the pregnancy that follows.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.